JSC „Grobiņa” Unaudited Consolidated Interim Report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JSC „Grobiņa” Unaudited Consolidated Interim Report 12/2014

Lapsu street 3, Dubeņi, Grobiņa parish, Grobiņa district, Zip : LV- 3411, 2015-02-27 16:11 CET (GLOBE NEWSWIRE) -- The Company's net sales for 2014 year amounted to € 2,879,362, and it has decreased by 23% compared to 2013 year. The Company's loss for 2014 year is € 1,657,441, but the 2014 year’s net loss per share is EUR -3,315, while the year 2013 net earnings per share were EUR 1,567.

In 2014 year’s 12 months were sold 94 849 mink skins on the average price of € 28.39 / pcs, which exceeded the Finnish mink auction average sales price, and however, was below the cost of production.

Despite the global fur fall in prices in 2014, JSC "Grobiņa" during the reporting period has been able to carry out ongoing investment projects in 2013, as a result of the JSC "Grobiņa" long-term investment to the end of 2014, constitute 15,223,427, -EUR, what  is about 6,022,704, -EUR more than in 2013 year. Thanks to the investments made in 2014 ,JSC "Grobiņa" has boosted its production gaining 120 000 mink skins.

As already JSC "Grobiņa" management predictored the 2014 year’s price collapse in the world fur was transitory nature, because since the beginning of the new season, fur sales in 2015, according to the January and February 2015 Auction Results in Danish auction house in Copenhagen and in the Canadian auction NAFA's house - the average realization price of mink skin in excess of 50 EUR /skin and reaches 100% of sales. All this confirms that this season the fur market has recovered and returned to the sales price what was in 2011-2013 year’s selling season limits, as a result of JSC "Grobiņa" management believes that in 2015 will be able to stabilize the company's cash flow and take the accumulated 2014 creditors' debts.

BALANCE SHEET    
  ASSETS 31.12.14.           EUR 31.12.13.           EUR
II Tangible assets    
  Land, building and construction 6 015 305 666 533
  Equipment and machinery 87 282 109 357
  Other fixed assets and equipment 762 132 347 674
  Construction in progress 1 371 393 5 230 874
  Advance payments for tangible assets 273 543 313 118
Total tangible assets 8 509 655 6 667 556
III Biological assets    
  Breeding animals 6 709 772 2 529 167
  Advance payments for breeding animals 4 000 4 000
Total biological assets 6 713 772 2 533 167
Total non-current assets 15 223 427 9 200 723
Current assets    
I Inventories    
  Raw materials and consumables 230 243 553 974
  Unfinished production 1 084 582 0
  Finished production and goods for sale 2 104 264 3 054 830
Total inventories 3 419 089 3 608 804
II Receivables    
  Trade receivables 108 544 2 319
  Other receivables 37 398 72 544
  Prepaid expenses 11 347 9 144
Total receivables 157 289 84 007
III Cash (total) 43 778 580 744
Total current assets 3 620 156 4 273 555
        Total assets 18 843 583 13 474 278
       
       
       
       
       
       
       
       
       
BALANCE SHEET (continued)      
  EQUITY AND LIABILITIES 31.12.14.           EUR 31.12.13.           EUR
I  Equity    
  Share capital (equity) 711 436 711 436
  Reserves:    
                       d) other reserves  77 481 77 481
  Total reserves 77 481 77 481
  Retained earnings    
                        a) retained earnings for the previous year 2 276 944 1 493 524
                        b) retained earnings for the reporting year -1 657 441 783 420
  Total retained earnings 619 503 2 276 944
Total equity 1 408 420 3 065 861
II Provisions    
  Other provisions 71 106 69 782
Total provisions 71 106 69 782
III Liabilities    
I Long-term liabilities    
  Loans from credit institutions 0 4 500 541
  Other loans 587 073 10 398
  Further period income 2 199 191 1 825 366
  Deferred tax liabilities 112 278 35 852
Total long-term liabilities 2 898 542 6 372 157
II Short-term liabilities    
  Loans from credit institutions 7 153 608 381 006
  Other loans 514 809 31 515
  Prepayments received from customers 2 302 548 2 344 865
  Trade payables 4 087 520 956 731
  Taxes and state social insurance payables 226 643 94 263
  Other payables 58 709 37 427
  Further period income 95 617 96 072
  Accrued liabilities 26 061 24 599
Total short-term liabilities 14 465 515 3 966 478
Total liabilities 17 364 057 10 338 635
        Total equity and liabilities 18 843 583 13 474 278
       
       
       
       
       
       
       
       
INCOME STATEMENT    
    2014          EUR 2013          EUR
  Net turnover 2 879 362 3 722 278
  Cost of sales 3 514 908 2 025 515
  Gross profit or loss -635 546 1 696 763
  Sales expenses 119 644 81 918
  Administrative expenses 417 056 465 561
  Other operating income 157 057 65 639
  Other operating expenses 74 210 74 160
  Profit or loss from operations -1 089 399 1 140 763
  Interest payable and similar expenses 482 189 229 963
  Profit or loss before extraordinary items and taxes -1 571 588 910 800
  Profit or loss before taxes -1 571 588 910 800
  Company income tax for the accounting year 0 82 195
  Deferred corporate income tax 76 426 35 852
  Other taxes 9 427 9 333
  Profit or loss of the reporting year -1 657 441 783 420
  Earnings (loss) per share (EPS) -3,315 1,567

 

 

 

 

         More information:          Gundars Jaunsleins          JSC “Grobiņa” Chairman of the Board          Tel: +371 26353885

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 34

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 0

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 2

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 41

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 1

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 0

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Launch of Plant-Based Fish Products by Steakholder Foods

Updated Category News Views 100

Steakholder Foods Launches Plant-Based Fish Products Steakholder Foods Ltd. (NASDAQ: STKH), an innovative leader in the alternative protein sector, has officially launched its first plant-based white fish kebabs and salmon patties in retail outlets. This exciting development marks a significant milestone in the company's journey to transform the seafood alternatives...

Continue Reading
The Incredible Growth of McKesson Stock Over Two Decades

Updated Category News Views 109

Understanding McKesson's Journey in the Market Over the past two decades, McKesson Corporation (NYSE: MCK) has demonstrated a remarkable ability to outperform the market, achieving an annualized return of 14.78%. This impressive performance translates to 6.3% above the typical market average, marking McKesson as a strong player in the healthcare sector. As of now, the...

Continue Reading
Tesla's Market Share Struggles As Competitors Surge Ahead

Updated Category News Views 197

Tesla's Market Share Challenges in the U.S. Tesla Inc. continues to face significant challenges as its market share in the U.S. electric vehicle (EV) sector drops below 40%. Recent data highlights that Tesla currently holds just 38% of this market, marking a substantial decrease since its peak in October 2017 when it commanded over 80% of the market. This shift implies an...

Continue Reading
Experience the Best of Mayan Culture at Eco-Guest House

Updated Category News Views 128

Eco-Guest House: A Unique Retreat in the Highlands Are you drawn to adventures in breathtaking natural landscapes but appreciate the comforts of a well-appointed stay? Nestled high in the misty mountains, Eco-Guest House at San Martín is your destination for relaxation and cultural immersion. Opened recently in a picturesque village, this ecolodge serves as a prime...

Continue Reading
Understanding the Impact of Stress on Fleet Drivers' Performance

Updated Category News Views 154

The Pressing Issue of Stress Among Fleet Professionals A recent study has shown that an alarming 68% of fleet professionals believe that stress has a negative impact on their driving performance. This statistic, derived from research by Geotab Inc., sheds light on the pressing need for heightened support aimed at commercial drivers. The implications are profound as they...

Continue Reading